These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23158562)

  • 61. Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus.
    Furukawa M; Kiyohara C; Tsukamoto H; Mitoma H; Kimoto Y; Uchino A; Nakagawa M; Oryoji K; Shimoda T; Akashi K; Harada M; Horiuchi T
    Rheumatol Int; 2011 Mar; 31(3):365-76. PubMed ID: 20020143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Retrospective Analysis of Longitudinal Changes in Bone Mineral Density in Women with Systemic Lupus Erythematosus.
    Mendoza-Pinto C; García-Carrasco M; Juárez-Melchor D; Munguía-Realpozo P; Etchegaray-Morales I; Santiago-Martín N; Ayón-Aguilar J; Méndez-Martínez S
    Calcif Tissue Int; 2021 Oct; 109(4):363-371. PubMed ID: 33864471
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment.
    Hansen M; Halberg P; Kollerup G; Pedersen-Zbinden B; Hørslev-Petersen K; Hyldstrup L; Lorenzen I
    Scand J Rheumatol; 1998; 27(3):197-206. PubMed ID: 9645415
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disease Damage Accrual and Low Bone Mineral Density in Female Patients with Systemic Lupus Erythematosus.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Ríos-Fernández R; Rueda-Medina B; Ortego-Centeno N
    Biol Res Nurs; 2021 Oct; 23(4):575-583. PubMed ID: 33787331
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reduced bone mineral density in Japanese premenopausal women with systemic lupus erythematosus treated with glucocorticoids.
    Banno S; Matsumoto Y; Naniwa T; Hayami Y; Sugiura Y; Yoshinouchi T; Ueda R
    Mod Rheumatol; 2002 Dec; 12(4):323-8. PubMed ID: 24384000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
    Korczowska I; Olewicz-Gawlik A; Hrycaj P; Lacki J
    Yale J Biol Med; 2003; 76(2):45-54. PubMed ID: 15369631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids.
    Li EK; Tam LS; Young RP; Ko GT; Li M; Lau EM
    Br J Rheumatol; 1998 Apr; 37(4):405-10. PubMed ID: 9619891
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone mineral density in juvenile systemic lupus erythematosus.
    Castro TC; Terreri MT; Szejnfeld VL; Castro CH; Fisberg M; Gabay M; Hilário MO
    Braz J Med Biol Res; 2002 Oct; 35(10):1159-63. PubMed ID: 12424488
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bone geometry, volumetric bone mineral density, microarchitecture and estimated bone strength in Caucasian females with systemic lupus erythematosus. A cross-sectional study using HR-pQCT.
    Hansen S; Gudex C; Åhrberg F; Brixen K; Voss A
    Calcif Tissue Int; 2014 Dec; 95(6):530-9. PubMed ID: 25326144
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
    Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
    J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment of the risk of low bone mineral density in premenopausal Japanese female patients with systemic lupus erythematosus.
    Mori Y; Baba K; Kogure A; Izumiyama T; Matsuda M; Mori N; Ishii T; Itoi E
    J Orthop; 2018 Mar; 15(1):89-93. PubMed ID: 29657446
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Sánchez-Guerrero J; Fragoso-Loyo HE; Neuwelt CM; Wallace DJ; Ginzler EM; Sherrer YR; McIlwain HH; Freeman PG; Aranow C; Petri MA; Deodhar AA; Blanton E; Manzi S; Kavanaugh A; Lisse JR; Ramsey-Goldman R; McKay JD; Kivitz AJ; Mease PJ; Winkler AE; Kahl LE; Lee AH; Furie RA; Strand CV; Lou L; Ahmed M; Quarles B; Schwartz KE
    J Rheumatol; 2008 Aug; 35(8):1567-75. PubMed ID: 18634158
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Carotid atherosclerosis is not associated with lower bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.
    Mendoza-Pinto C; García-Carrasco M; Jiménez-Hernández M; Sánchez-Pérez R; Escárcega RO; Nava-Zavala A; Munguía-Realpozo P; López-Colombo A; Jara LJ; Cervera R
    Lupus; 2015 Jan; 24(1):25-31. PubMed ID: 25159099
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone mineral density and hormonal status in men with systemic lupus erythematosus.
    Formiga F; Nolla JM; Mitjavila F; Bonnin R; Navarro MA; Moga I
    Lupus; 1996 Dec; 5(6):623-6. PubMed ID: 9116708
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus.
    Mok CC; Mak A; Ma KM
    Lupus; 2005; 14(2):106-12. PubMed ID: 15751814
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low disease activity state associated with fewer incident vertebral fractures in Mestizo women with systemic lupus erythematosus.
    Mendoza-Pinto C; Etchegaray-Morales I; Munguía-Realpozo P; Osorio-Peña ÁD; Méndez-Martínez S; Ramírez-Lara E; Zárate-Arellano D; Solis-Poblano JC; Ayón-Aguilar J; García-Carrasco M
    Lupus; 2023 Oct; 32(11):1328-1334. PubMed ID: 37705367
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus.
    Mok CC; To CH; Ma KM
    Lupus; 2008 Nov; 17(11):1018-22. PubMed ID: 18852226
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
    Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
    J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS.
    Stagi S; Cavalli L; Bertini F; Matucci Cerinic M; Luisa Brandi M; Falcini F
    Lupus; 2014; 23(1):57-68. PubMed ID: 24218395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.